MondayMar 04, 2024 11:00 am

Study Links Parkinson’s Onset in Rocky Mountain Area to Agricultural Pesticides

Preliminary research has found that herbicides and pesticides used in farming may be associated with Parkinson’s disease. For their research, the investigators reviewed records from more than 20 million individuals obtained from Medicare. The objective of the researchers was to calculate the rate of Parkinson’s disease for different regions in the country. They also examined possible links between the use of more than 60 pesticides and rates of Parkinson’s disease. The author of the study, Brittany Krzyzanowski, explained that the team of investigators utilized geographic techniques to study the disorder’s rates then compared their findings to regional levels of herbicide…

Continue Reading

MondayMar 04, 2024 10:30 am

Astiva Health Inc. CEO Featured Podcast Guest, Talks Commitment to Help Patients Enjoy ‘Active, Healthy and Meaningful’ Lives

In addition to providing full medical-care prescription drugs, Astiva focuses on providing rich supplemental benefits to enrollees CEO explains that “effective healthcare hinges largely on patient involvement” Astiva’s recent expansion is a crucial step in extending invaluable benefits and commitment to quality healthcare to a growing, diverse population Astiva Health CEO Dr. Tri Nguyen was the featured guest in a recent Bell2Bell Podcast release (https://ibn.fm/0Rufk). During the podcast, Nguyen talked provided an in-depth look at how Astiva Health is reshaping healthcare delivery, including an overview of the company’s commitment to patient involvement in healthcare and highlights the company’s innovative strategies in offering comprehensive…

Continue Reading

FridayMar 01, 2024 11:30 am

A Comparison Between ALS, Parkinson’s Disease

Parkinson’s disease and amyotrophic lateral sclerosis (ALS) are conditions that affect an individual’s nervous system and brain. Both conditions also cause tremors during the early stages, which can affect an individual’s movement. Despite their similarities, however, the conditions require different treatments to manage their symptoms. Below, we look at the similarities and differences between ALS and Parkinson’s disease. What is Parkinson’s disease? This condition destroys cells in the basal ganglia, which makes it hard for individuals to control their movements. Data from the Parkinson’s Foundation shows that about 90,000 individuals are diagnosed with this condition annually in America. This condition’s…

Continue Reading

WednesdayFeb 28, 2024 9:45 am

Siteman Cancer Center Starts Offering Novel Cell-Based Immunotherapy Against Melanoma

Patients with melanoma may soon be able to access a new immunotherapy that was recently approved by the U.S. Food and Drug Administration (FDA). The cell-based treatment, which was developed by Iovance Therapeutics, will first be administered by physicians at the Siteman Cancer Center in Washington University before it can be commercialized under the name Amtagvi. The tumor-infiltrating lymphocyte immunotherapy has been designed for the treatment of metastatic melanoma, which is a skin cancer that has spread to other parts of the body. The treatment, called lifileucel, has been designed specifically for patients suffering from this particular cancer whose tumor…

Continue Reading

TuesdayFeb 27, 2024 12:00 pm

Astiva Health Inc. Championing Culturally Sensitive Healthcare for Aging Asian American Population

By 2060, the older Asian population in the U.S. is expected to reach 8.5 million, making up 9% of the country's elderly demographic, signaling a significant increase from 4% in 2014 Astiva Health is leading the charge in creating essential healthcare solutions tailored for this expanding demographic, demonstrating a deep understanding of their unique healthcare needs Astiva Health has introduced groundbreaking programs, including language-specific healthcare services and wellness initiatives, specifically designed for the diverse aging Asian American community Astiva Health is working serve the Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the…

Continue Reading

TuesdayFeb 27, 2024 11:15 am

Astrotech Corp. (NASDAQ: ASTC) Reports 512% Jump in YTD Revenue

Astrotech reported financial results for the quarter ended December 31, 2023, recording year-to-date revenue of $1,540,000 The company attributed the growth to the successful fulfillment of two significant purchase orders for the TRACER 1000(TM), the world’s first mass spectrometer-based explosive trace detectors (“ETD”), to customers in Romania Astrotech is focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries 1st Detect Corp., AgLAB Inc., Pro-Control Inc., and BreathTech Corp. The company and its subsidiaries are positioned to capitalize on burgeoning markets, including the global mass spectrometry market, expected to grow from an estimated $6.77 billion in…

Continue Reading

TuesdayFeb 27, 2024 10:30 am

Sigyn Therapeutics Inc. (SIGYD) Completes Reverse Stock Split, Releases Year-End Financial Report for 2023

Sigyn's common stock, temporarily trading under the ticker symbol "SIGYD", is set to revert back to its historic symbol "SIGY" on February 29, 2024. The company, as part of its 2023 Year-End Report, summarized its development of medical technologies that target to overcome clearly defined limitations in global health. During 2023, Sigyn expanded its line-up of medical technologies designed to enhance the benefit of cancer therapies. The company’s cancer treatment pipeline now includes ImmunePrep(TM), ChemoPrep(TM), and ChemoPure(TM).   The company believes the successful clinical advancement of Sigyn Therapy(TM) to treat pathogen-associated conditions beyond the reach of drugs, may offer a…

Continue Reading

MondayFeb 26, 2024 9:30 am

Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer

Figures show that brain cancer occurs in less than 1% of the population in America. At least one-third of individuals diagnosed with primary brain cancer tumors survive for at least five years. Those with glioblastoma, a common type of brain cancer, have about a 14% chance of living an additional five years. This is dependent on the age of diagnosis, however. While what causes brain cancer is still unknown, scientists theorize that exposure to ionized radiation may be linked to this illness. Now, new research has found that veterans who experience head injuries have a heightened risk of developing brain…

Continue Reading

FridayFeb 23, 2024 10:30 am

Sigyn Therapeutics Inc. (SIGYD) CEO Discusses Opportunities to Treat Cancer and Drug-Resistant Pathogens in Letter to Shareholders

Sigyn Therapeutics Chairman and CEO James A. Joyce recently provided a letter to shareholders that discussed the company’s therapeutic opportunities, challenges, and decision-making processes The letter overviewed the company’s candidate technologies to enhance the performance of cancer therapies (ImmunePrep(TM), ChemoPrep(TM), and ChemoPure(TM)), and provided an update on Sigyn Therapy(TM), an extracorporeal drug purification technology to address pathogen-associated conditions that are beyond the reach of drugs James A. Joyce, the Chairman and CEO of development-stage medical technology company Sigyn Therapeutics (OTCQB: SIGYD, SIGY), recently discussed the company’s opportunities, challenges, and decision-making processes in a letter to shareholders (https://ibn.fm/wGTqS). The company is currently…

Continue Reading

FridayFeb 23, 2024 10:00 am

Challenges Faced in Upholding Medical Ethics in Safety-Net Healthcare Systems

Safety-net health systems are critical to providing adequate healthcare to underserved populations such as ethnic or racial minorities and uninsured and low-income individuals. A September 2023 Census Bureau report noted that 7.9% of the American population, or 26 million people, were uninsured in 2022. Several studies have also shown that racial and ethnic minorities are more likely to face challenges when trying to access medical care in North America. Black, Hispanic and Asian populations appear to have lower access to health insurance coverage in the United States, with Hispanic individuals reportedly facing more significant barriers to accessing health insurance. Safety-net…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050